Inmaculada Monleón

1.1k total citations
15 papers, 926 citations indexed

About

Inmaculada Monleón is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Inmaculada Monleón has authored 15 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Inmaculada Monleón's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (5 papers) and Cell death mechanisms and regulation (3 papers). Inmaculada Monleón is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (5 papers) and Cell death mechanisms and regulation (3 papers). Inmaculada Monleón collaborates with scholars based in Spain, United States and France. Inmaculada Monleón's co-authors include Javier Naval, Alberto Anel, María A. Álava, María José Martínez‐Lorenzo, Andrés Piñeiro, Pilar Lasierra, Luis Larrad, Susana Gamen, Marı́a Iturralde and Manuel Sarasa and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and European Journal of Immunology.

In The Last Decade

Inmaculada Monleón

15 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inmaculada Monleón Spain 12 554 360 224 144 87 15 926
Robert Nechanitzky Canada 10 452 0.8× 282 0.8× 81 0.4× 75 0.5× 21 0.2× 13 858
Jennifer S. McKay United Kingdom 17 525 0.9× 124 0.3× 164 0.7× 58 0.4× 32 0.4× 37 1.2k
Swamy K. Polumuri United States 16 278 0.5× 361 1.0× 84 0.4× 49 0.3× 27 0.3× 20 735
Christopher Fisher United States 18 485 0.9× 61 0.2× 388 1.7× 64 0.4× 76 0.9× 30 992
Monica Wei United States 10 416 0.8× 122 0.3× 160 0.7× 165 1.1× 24 0.3× 15 821
Maurice Zauderer United States 23 515 0.9× 536 1.5× 71 0.3× 31 0.2× 37 0.4× 72 1.4k
Svenja Debey Germany 11 485 0.9× 646 1.8× 46 0.2× 121 0.8× 41 0.5× 12 1.6k
Marina Morel France 13 377 0.7× 206 0.6× 117 0.5× 28 0.2× 29 0.3× 19 843
Nikolai N. Belyaev Kazakhstan 14 347 0.6× 248 0.7× 135 0.6× 58 0.4× 10 0.1× 26 790
Catherine Pythoud Switzerland 14 429 0.8× 179 0.5× 112 0.5× 81 0.6× 12 0.1× 18 819

Countries citing papers authored by Inmaculada Monleón

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Monleón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Monleón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Monleón more than expected).

Fields of papers citing papers by Inmaculada Monleón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Monleón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Monleón. The network helps show where Inmaculada Monleón may publish in the future.

Co-authorship network of co-authors of Inmaculada Monleón

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Monleón. A scholar is included among the top collaborators of Inmaculada Monleón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Monleón. Inmaculada Monleón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pérez‐Grijalba, Virginia, Javier Arbizu, Judith Romero, et al.. (2019). Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimer s Research & Therapy. 11(1). 96–96. 39 indexed citations
2.
Pascual‐Lucas, María, Pedro Pesini, Virginia Pérez‐Grijalba, et al.. (2018). Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial. Alzheimer s Research & Therapy. 10(1). 12–12. 81 indexed citations
3.
4.
Pérez‐Grijalba, Virginia, Pedro Pesini, Inmaculada Monleón, et al.. (2013). Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment. Journal of Alzheimer s Disease. 36(1). 211–219. 16 indexed citations
5.
Sarasa, Leticia, José Antonio Allué, Inmaculada Monleón, et al.. (2012). O2‐03‐05: Beta‐amyloid‐17 is a major beta‐amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value. Alzheimer s & Dementia. 8(4S_Part_7). 6 indexed citations
6.
Aguiló, Nacho, Marı́a Iturralde, Inmaculada Monleón, et al.. (2012). Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: Reactive oxygen species generation and inactive shortened SOD1 isoform implications. Chemico-Biological Interactions. 198(1-3). 18–28. 15 indexed citations
7.
Pesini, Pedro, Virginia Pérez‐Grijalba, Inmaculada Monleón, et al.. (2012). Reliable Measurements of theβ-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD. International Journal of Alzheimer s Disease. 2012. 1–10. 45 indexed citations
8.
González‐Martínez, Ángela, Belén Rosado, Pedro Pesini, et al.. (2011). Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease. Experimental Gerontology. 46(7). 590–596. 50 indexed citations
9.
Modrego, Pedro J., Inmaculada Monleón, & Manuel Sarasa. (2008). The Clinical Significance of Plasmatic Amyloid Aβ-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine. American Journal of Alzheimer s Disease & Other Dementias®. 23(3). 286–290. 3 indexed citations
10.
Monleón, Inmaculada, Marı́a Iturralde, María José Martínez‐Lorenzo, et al.. (2002). Lack of Fas/CD95 surface expression in highly proliferative leukemic cell lines correlates with loss of CtBP/BARS and redirection of the protein toward giant lysosomal structures.. PubMed. 13(7). 315–24. 4 indexed citations
11.
Monleón, Inmaculada, María José Martínez‐Lorenzo, Luís V. Monteagudo, et al.. (2001). Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells. The Journal of Immunology. 167(12). 6736–6744. 215 indexed citations
12.
Pardo, Julián, Patricia Pérez‐Galán, Susana Gamen, et al.. (2001). A Role of the Mitochondrial Apoptosis-Inducing Factor in Granulysin-Induced Apoptosis. The Journal of Immunology. 167(3). 1222–1229. 95 indexed citations
13.
Monleón, Inmaculada, María José Martínez‐Lorenzo, Alberto Anel, et al.. (2000). CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells. European Journal of Immunology. 30(4). 1078–1087. 27 indexed citations
14.
Martínez‐Lorenzo, María José, Alberto Anel, Inmaculada Monleón, et al.. (2000). Tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemia. The International Journal of Biochemistry & Cell Biology. 32(4). 435–445. 32 indexed citations
15.
Martínez‐Lorenzo, María José, Alberto Anel, Susana Gamen, et al.. (1999). Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles. The Journal of Immunology. 163(3). 1274–1281. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Nechanitzky Breakdown of academic impact, for papers by Jennifer S. McKay Breakdown of academic impact, for papers by Swamy K. Polumuri Breakdown of academic impact, for papers by Christopher Fisher Breakdown of academic impact, for papers by Monica Wei Breakdown of academic impact, for papers by Maurice Zauderer Breakdown of academic impact, for papers by Svenja Debey Breakdown of academic impact, for papers by Marina Morel Breakdown of academic impact, for papers by Nikolai N. Belyaev Breakdown of academic impact, for papers by Catherine Pythoud
Rankless by CCL
2026